IPSEN

IPN
Real-time Euronext Paris - 11:35 2022-12-01 am EST
107.20 EUR  0.00%

Turn to zoom
Prev.107.20000000
Open108.00000000
High108.10000000
Low106.30000000
Volume80 623
Latest news
11/10
11/10
11/09
11/09
Chart IPSEN
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishNeutral
Resistance110110116
Spread/Res.-2,6%-2,6%-7,2%
Spread/Supp.3,1%16%36%
Support10492,279,0
Financials
Sales 2022 3 050 M 3 146 M 3 146 M
Net income 2022 805 M 831 M 831 M
Net cash 2022 604 M 623 M 623 M
P/E ratio 2022 10,7x
Yield 2022 1,11%
Capitalization 8 834 M 9 110 M 9 110 M
EV / Sales 2022 2,70x
EV / Sales 2023 2,42x
Nbr of Employees 5 744
Free-Float 41,3%
Company
Ipsen specializes in the research, development, manufacturing and marketing of medications. Sales break down by family of products as follows:
- specialty drugs (92.1%). Sales break down by therapeutic area between oncology (81.4%), neuroscience (1516.7 and rare diseases (1.9%);
- consumer...
Sector :
Other Pharmaceuticals
Calendar :
2023-02-09 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 107,20 €
Average target price 108,88 €
Spread / Average Target 1,56%